药物受理最新动态：Bristol-Myers Squibb CompanyBMS-986510...

Core Viewpoint - The application for BMS-986510 capsules by Bristol-Myers Squibb Company has been accepted by the National Medical Products Administration, indicating progress in the drug approval process [1] Group 1: Application Details - The application acceptance date for BMS-986510 capsules is December 31, 2025 [1] - The application number for the drug is JXHL2500401 [1] - The drug type is classified as a chemical drug with an import registration application type [1] Group 2: Company Information - The application is associated with Bristol-Myers Squibb Company and its subsidiary, Bristol-Myers Squibb (China) Investment Co., Ltd. [1]